Members

I am co-leader of the Leukemia and Hematologic Malignancies (LHM) program at the OSUCCC – James, where my research focus is on epigenetic alterations of cancer cells and the development of experimental therapeutics for hematologic disease.

I work on factors that regulate fate decision in activated B cells.

I am a board-certified hematologist who specializes in treating cancers that are centered in the lymph nodes.

I am a professor and chair of the Division of Biostatistics at The Ohio State University College of Public Health and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James.

I am a medical oncologist who treats patients with blood cancers.

I am a member of the Leukemia Research Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research broadly covers translational and clinical pharmacology of anticancer agents. I also hold the Gertrude Parker Heer Chair in Cancer Research.

I’m a hematologist-oncologist and provide clinical, inpatient care of patients with acute myeloid leukemia and acute lymphocytic leukemia.

I’m a hematologist-oncologist caring for patients with multiple myeloma, amyloidosis and those undergoing blood and marrow transplantation.

I am a hematologist who specializes in treating patients with chronic lymphocytic leukemia (CLL).

I’m an oncologist focused on the treatment of patients diagnosed with hairy cell leukemia, acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and chronic lymphocytic leukemia (CLL).

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where I seek to identify factors in the hematopoietic niche that promote the development of myeloid neoplasia.

I am a hematologist specializing in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and clonal cytopenias of unknown significance.

I’m a hematologist specializing in patients with T-cell lymphoma, T-cell leukemia, non-Hodgkin lymphoma, and allogenic and autologous stem cell transplantation.

As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, I seek to improve the efficacy of antibody therapy through my research.

I bring an engineering perspective as a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where I seek to use engineering approaches with nanotechnology and biophysics experimental tools to characterize and model physical properties and behaviors of complex biological systems.

I am a hematologist who specializes in blood and marrow stem cell transplantation and treating patients with myeloid diseases, including acute myeloid leukemia (AML), myeloproliferative diseases and other conditions requiring allogeneic stem cell transplantation.

I am a hematologist and oncologist who specializes in treating patients with aggressive and indolent B-cell non-Hodgkin’s and Hodgkin’s lymphoma.

I am an Associate Professor in the Division of Pharmaceutics & Pharmacology at The Ohio State University College of Pharmacy and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James.

I am an assistant professor in the Department of Microbial Infection and Immunity at The Ohio State University and a member of the Cancer Biology Program at the OSUCCC – James, where my research focuses on genomic mechanisms that balance immune development and disease.

I am a hematologist who specializes in the treatment of patients with plasma cell disorders, such as multiple myeloma and amyloidosis.

I am a hematologist who specializes in hematopoietic cell transplantation for patients who have been diagnosed with leukemia.

I am an associate professor in the Division of Hematology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my lab focuses primarily on understanding the genomic underpinnings of acute myeloid leukemia (AML).

I am a professor and associate dean for research and graduate studies in the College of Veterinary Medicine at The Ohio State University, where I also direct the Center for Retrovirus Research.

I am a hematologist who specializes in treating patients with leukemia and other blood cancers.

I am a medical oncologist who specializes in treating patients with blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome.

I am an assistant professor in the Department of Microbial Infection and Immunity at The Ohio State University and a member of the Translational Therapeutics Program at the OSUCCC – James.

I am a hematologist who specializes in the treatment of malignant blood cancers, specifically lymphomas.

I am an associate professor in the Division of Hematology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on innate and adaptive immune responses in viral infections and cancer.

I am a research scientist with a multidisciplinary background in bioengineering and cellular gene therapy.

I am a hematologist who specializes in treating patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

I am a hematologist with specialties in acute myeloid leukemia (AML) and blood and marrow transplant (BMT).

I am the director of the Cellular Therapy and Cancer Immunology Program at Nationwide Children’s Hospital and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on approaches to enhance natural killer (NK) cell response to cancer, with an emphasis on engineering NK cells for adoptive immunotherapy.

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research centers on nanoparticle-based drug delivery systems.

I am a research scientist and assistant professor in the Department of Microbial Infection and Immunity at The Ohio State University.

I am a professor in the Division of Hematology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on cancer immunotherapy, tumor immunology and innate immunity.

As a hematologist-oncologist, I have a special interest in treating patients with chronic lymphocytic leukemia (CLL).

I am a hematologist who specializes in treating patients with B-cell malignancies, such as non-Hodgkin’s lymphoma (NHL), Hodgkin’s lymphoma (HD) and chronic lymphocytic leukemia (CLL).

I am an assistant professor in the Department of Pathology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James.

I am an associate professor with tenure in the Department of Internal Medicine, Division of Hematology at The Ohio State University and a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James.

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on several areas, including biological therapies for hematologic malignancies, the development and characterization of clinically relevant animal models of lymphoid malignancies and targeted delivery of RNA-based therapeutics in lymphoid and myeloid malignancies.

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research explores the use of humanized mice and rabbits as animal models for infection with human T cell leukemia virus and leukemia development.

As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, I focus on investigating and understanding the role of epigenetics in normal development and carcinogenesis.

As a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, I focus my research on human T-cell leukemia virus type 1 (HTLV-1), the causative infectious agent of adult T-cell leukemia/lymphoma, which typically occurs after an extensive clinical latency period upward of several decades and lacks ideal therapeutic strategies.

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where I use my expertise in analytical methodologies and data modeling to study novel anticancer agents.

My work is focused on investigating the mechanisms regulating dysfunctional immune responses following an allogeneic hematopoietic cell transplant.

I am a hematologist who specializes in treating patients with lymphoma.

I am a hematologist-oncologist dedicated to advancing the care and treatment of patients with chronic lymphocytic leukemia (CLL) and autoimmune cytopenias.

I am a hematologist in the Department of Bone and Marrow Transplant and Cellular Therapy at the OSUCCC – James.

I am a translational scientist and an assistant professor in the Division of Hematology at The Ohio State University.

I am a hematologist who specializes in treating patients diagnosed with blood disorders, such as leukemia, lymphoma and sickle cell disease.

I am a principal investigator in the Center for Childhood Cancer & Blood Diseases at the Abigail Wexner Research Institute at Nationwide Children’s Hospital and an assistant professor in the Department of Pediatrics at The Ohio State University College of Medicine.

I am a member of the Leukemia and Hematologic Malignancies Program at the OSUCCC – James, where my research focuses on molecular mechanisms of innate immune responses to bacterial pathogens and immunoglobulin G complexes.

I treat a variety of blood cancers and benign blood disorders in my role as a hematologic oncologist.

I am a hematologist-oncologist who specializes in treating patients with acute myeloid leukemia (AML), myelodysplastic syndromes and bone marrow transplantation.

I am a hematologist-oncologist with a particular interest in myeloproliferative neoplasms and benign hematologic conditions.

I am a genomics scientist and an associate research professor of Internal Medicine in the Division of Hematology.